About Calico Biolabs
Calico Biolabs is a company based in Pleasanton (United States) founded in 2012 was acquired by Abcam in January 2019. Calico Biolabs offers products and services including Primary Antibodies, ELISA Kits, and Cell Lines. Calico Biolabs operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Pleasanton, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abcam Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Calico Biolabs
Calico Biolabs offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, and Cell Lines.
Highly cited antibodies for precise research applications.
Tools for consistent immunoassays in life science studies.
Validated gene-edited lines for advanced research purposes.
Funding Insights of Calico Biolabs
Detailed funding history for Calico Biolabs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Calico Biolabs
Calico Biolabs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abcam.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biological reagents and antibodies are developed for life science research.
|
Locked | Locked | Locked |
Investor details for Calico Biolabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Calico Biolabs
Investment portfolio details for Calico Biolabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Calico Biolabs
Detailed financials for Calico Biolabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Calico Biolabs Comparisons
Peer comparison for Calico Biolabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Calico Biolabs
Calico Biolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Calico Biolabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Calico Biolabs
Complete news archive for Calico Biolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Calico Biolabs
Calico Biolabs was founded in 2012.
Calico Biolabs is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Calico Biolabs was founded in 2012 in Pleasanton, United States, as a biotechnology firm specializing in antibody development. It operates as a part of Abcam, with a focus on custom rabbit monoclonal antibodies tailored for research and clinical laboratories, including ELISA assays. Products are designed specifically for immunohistochemical applications. Services provided encompass polyclonal and monoclonal antibody development, tissue sectioning, and process optimization for various laboratory needs.
Calico Biolabs's top competitors include Sino Biological, GenScript and Y-Biologics.
Calico Biolabs offers Primary Antibodies, ELISA Kits, and Cell Lines.
Calico Biolabs has 1 investor. Key investors include Abcam.